Sandra Abrevaya

May 27, 2024 | joethemnmovieman.com | Brian Wallach |Christopher Burke |Sandra Abrevaya

Synopsis: One couple’s fight to reclaim their future from a brutal disease has snowballed into a movement with resounding ramifications for the ALS community and millions of patients seeking a voice in our broken healthcare system.

Apr 19, 2023 | synapticure.com | Sandra Abrevaya

Synapticure proudly announces our recently IRB-approved study that focuses on presymptomatic individuals who carry a pathogenic or likely-pathogenic gene variant of ALS. Participants in this study will be given the option to take Riluzole, one of the FDA-approved treatments for ALS. There is no placebo for this study, so all eligible participants will receive the medication. Who is eligible?

Mar 1, 2023 | newsweek.com | Sandra Abrevaya

When you meet someone and fall in love, you imagine that you'll live out your love story together, without an audience—just you, your family and your friends. It never crosses your mind that a diagnosis, and how your family responds to it, will lead to perfect strangers asking about your story. I never expected that would happen to me, but it did.